Skip to content
SFB-Pharma

SFB-Pharma

  • Office
  • Contact
  • About Us
Posted on 11 October 202111 October 2021 by Christine Laroche

Bienvenue dans – Welkom bij:

Bienvenidos en – Welcome to:

SFB-Pharma

If you want to reach me please send a message to:

Christine Laroche  claroche@sfb-pharma.com

Recent Posts

  • (no title)

Archives

  • October 2021

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

RSS Drugs.com – New Drug Approvals

  • FDA Approves Genentech’s Tecentriq as Adjuvant Treatment for Certain People With Early Non-Small Cell Lung Cancer
  • U.S. FDA Approves Cyltezo (adalimumab-adbm) as First Interchangeable Biosimilar with Humira
  • FDA Approves Verzenio (abemaciclib) as the First and Only CDK4/6 Inhibitor for Certain People with HR+ HER2- High Risk Early Breast Cancer
  • FDA Approves Merck’s Keytruda (pembrolizumab) Plus Chemotherapy, With or Without Bevacizumab, as Treatment for Patients With Persistent, Recurrent or Metastatic Cervical Cancer Whose Tumors Express PD-L1 (CPS ≥1)

SFB-Pharma Info

  • About Us
  • Contact
  • Office
Proudly powered by WordPress